In a 2020 study focusing on pediatric B-ALL, Blaeschke and colleagues identified a significant overexpression of TIM-3, individually and in conjunction with PD-1, on CD4+ T cells in the bone marrow. The gene discussed is HAVCR2; the disease is precursor B-cell acute lymphoblastic leukemia.